以兹提米比
医学
瑞舒伐他汀
他汀类
内科学
危险系数
临床终点
心脏病学
物理疗法
随机对照试验
置信区间
作者
Seung‐Jun Lee,Jung‐Joon Cha,Woong Choi,Wang Soo Lee,Jin‐Ok Jeong,Seonghoon Choi,Yoon-Haeng Cho,Woo Jung Park,Jung‐Kyu Han,Yong‐Joon Lee,Sung‐Jin Hong,Chul‐Min Ahn,Byeong‐Keuk Kim,Young‐Guk Ko,Donghoon Choi,Myeong‐Ki Hong,Yangsoo Jang,Soon Jun Hong,Jung‐Sun Kim,Kyeong Ho Yun
出处
期刊：JAMA Cardiology
[American Medical Association]
日期：2023-08-02
卷期号：8 (9): 853-853
被引量：12
标识
DOI：10.1001/jamacardio.2023.2222
摘要
High-intensity statin is strongly recommended in patients at very high risk (VHR) of atherosclerotic cardiovascular disease (ASCVD). However, concerns about statin-associated adverse effects result in underuse of this strategy in practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
热心市民小红花
SYLH
yznfly
眼睛大雨筠
ED
pluto
彭于彦祖
LaTeXer
昏睡的蟠桃
May
眯眯眼的衬衫
8R60d8
Sandy
Singularity
pcr163
知许解夏
GingerF
归尘
yydragen
yar
皖公网安备34019202002308
